• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Recalls

Pediatricians Demand Recall of Fisher-Price’s Rock ‘n Play Sleeper

By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
April 10, 2019, 11:54 AM ET

The American Academy of Pediatrics (AAP) is calling on Fisher-Price to recall its Rock ‘n Play Sleeper, saying the device is a threat to the life of newborns.

“This product is deadly and should be recalled immediately,” said Kyle Yasuda, MD, FAAP, president of the American Academy of Pediatrics in a statement. “There is convincing evidence that the Rock ‘n Play inclined sleeper puts infants’ lives at risk, and [the U.S. Consumer Product Safety Commission (CPSC)] must step up and take immediate action to remove it from stores and prevent further tragedies.”

The CPSC has already warned parents to stop using the sleeper when children turn three months old or are able to turn themselves over, citing 10 deaths, but a report from Consumer Reports this week said the device was actually responsible for 32 infant deaths since its introduction in 2009.

Rachel Moon, chair of the AAP task force on SIDS, said the sleeper does not meet the organization’s recommendations “for a safe sleep environment for any baby. Infants should always sleep on their back, on a separate, flat and firm sleep surface without any bumpers or bedding.”

The AAP’s call for the product’s recall echoes Consumer Reports. That publication also called on government safety officials to give other inclined infant sleepers are much closer look, as those, too, run counter to the AAP’s sleep recommendations for newborns and infants.

Several children’s products have been recalled over the past year. In December, 2018, infant ibuprofen was recalled over concerns the dosage was too strong. Nearly two months later, the same company recalled more ibuprofen for the same reason. And last August, Pfizerrecalled children’s Advil on overdose fears.

About the Author
By Chris MorrisFormer Contributing Writer

Chris Morris is a former contributing writer at Coins2Day, covering everything from general business news to the video game and theme park industries.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.